Statistics for The CALCIPHYX study: a randomized, double-blind, placebo-controlled, Phase 3 clinical trial of SNF472 for the treatment of calciphylaxis
Total visits
| views | |
|---|---|
| The CALCIPHYX study: a randomized, double-blind, placebo-controlled, Phase 3 clinical trial of SNF472 for the treatment of calciphylaxis | 53 |
Total visits per month
| views | |
|---|---|
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 1 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
File Visits
| views | |
|---|---|
| java.util.UUID:b57252ed-cfee-4766-8fae-8d34148cd10a | 82 |
| sfab117.pdf | 59 |
| java.util.UUID:e4d1983b-c8df-43e6-bdb9-8ad159b5b52f | 30 |
| java.util.UUID:b00c6007-7ab0-4a3b-903c-1b08bf7e3660 | 10 |
Top country views
| views | |
|---|---|
| United States | 44 |
| Bulgaria | 2 |
| Canada | 1 |
| United Kingdom | 1 |
| Russia | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 37 |
| Corydon | 3 |
| Sofia | 2 |
| Ann Arbor | 1 |
| Mount Laurel | 1 |
| Vancouver | 1 |
| Voronezh | 1 |
| Warrington | 1 |